An artificial alternative to antibiotics has been developed to fight hospital superbugs such as MRSA, according to an article on Forbes.com. The drug, Staphefekt, is reported to be the first new type of weapon to be added to the medical arsenal against infection in a quarter of a century.
Five out of six patients with MRSA (methicillin-resistant Staphylococcus aureus) skin infections were cured in a small-scale trial at the Public Health Laboratory in Kennemerland, the Netherlands, scientists reported at the Antibiotic Alternatives for the New Millennium conference in London yesterday, on Nov. 5.
Click here to read the entire article.
Source: Forbes.com
Latest from Quality Assurance & Food Safety
- Chef Robotics Introduces Pat-Down Capability for Meal Presentation and Sealing
- USDA Launches Regenerative Pilot Program
- Indoor Ag-Con Adds Food Safety Track to Conference Lineup
- IDFA Recognizes Federal Officials for Support of U.S. Dairy Industry
- Tetra Pak Acquires Bioreactors.net
- Fresh Del Monte Receives Rabobank Leadership Award
- São Paulo Earns Guinness World Record for Largest Municipal Food Security Program
- KPM Analytics Releases Ready-to-Use NIR Calibration Packages
